Vilin Bio Med (NSE:VILINBIO) Equity-to-Asset : 0.76 (As of Sep. 2023)

View and export this data going back to 2023. Start your Free Trial

What is Vilin Bio Med Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Vilin Bio Med's Total Stockholders Equity for the quarter that ended in Sep. 2023 was ₹234.47 Mil. Vilin Bio Med's Total Assets for the quarter that ended in Sep. 2023 was ₹309.44 Mil. Therefore, Vilin Bio Med's Equity to Asset Ratio for the quarter that ended in Sep. 2023 was 0.76.

The historical rank and industry rank for Vilin Bio Med's Equity-to-Asset or its related term are showing as below:

NSE:VILINBIO' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.52 Med: 0.54 Max: 0.76
Current: 0.76

During the past 3 years, the highest Equity to Asset Ratio of Vilin Bio Med was 0.76. The lowest was 0.52. And the median was 0.54.

NSE:VILINBIO's Equity-to-Asset is ranked better than
75.94% of 1085 companies
in the Drug Manufacturers industry
Industry Median: 0.59 vs NSE:VILINBIO: 0.76

Vilin Bio Med Equity-to-Asset Historical Data

The historical data trend for Vilin Bio Med's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vilin Bio Med Equity-to-Asset Chart

Vilin Bio Med Annual Data

Trend

Mar20

Mar21

Mar22

Equity-to-Asset

0.52

0.53

0.55

Vilin Bio Med Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Sep23
Equity-to-Asset	0.52	0.53	0.55	-	0.76

Competitive Comparison of Vilin Bio Med's Equity-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Vilin Bio Med's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Vilin Bio Med's Equity-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Vilin Bio Med's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Vilin Bio Med's Equity-to-Asset falls into.

Vilin Bio Med Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Vilin Bio Med's Equity to Asset Ratio for the fiscal year that ended in Mar. 2022 is calculated as

Equity to Asset (A: Mar. 2022 )	=	Total Stockholders Equity	/	Total Assets
	=	73.962	/	135.583
	=	0.55

Vilin Bio Med's Equity to Asset Ratio for the quarter that ended in Sep. 2023 is calculated as

Equity to Asset (Q: Sep. 2023 )	=	Total Stockholders Equity	/	Total Assets
	=	234.467	/	309.444
	=	0.76

Vilin Bio Med (NSE:VILINBIO) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Vilin Bio Med Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of Vilin Bio Med's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Vilin Bio Med (NSE:VILINBIO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Vilin Bio Med Ltd (NSE:VILINBIO) » Definitions » Equity-to-Asset

Traded in Other Exchanges

N/A

Address

Opposite Sub Registrar’s Office, Survey No.115/GF/J, Hanumanji Colony, Bowempally, Secunderabad, TG, IND, 500009

Website

http://www.vilinbiomed.co.in

Vilin Bio Med Ltd is engaged in the domestic business of manufacturing Pharmaceuticals products. It is manufacturing pharmaceutical formulations such as Oral Liquids, Dry syrups, Sachets, External Preparations, Beta and Non-Beta Lactam tablets, and Capsules & Nutritional Food supplements.

Vilin Bio Med (NSE:VILINBIO) Headlines

No Headlines